AnnJi Pharmaceutical
Manufacturing · Taiwan · 11-50 Employees
View Company Info for Free
Overview
Headquarters
16f.-6 No. 508 Sec. 7 Zhongxiao E. Rd. N...Website
www.ajpharm.comRevenue
$18.3 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About AnnJi Pharmaceutical
安基生技新藥股份有限公司 is a clinical-stage pharmaceutical company focused on the development of innovative small molecules (NCEs) targeting unmet medical needs in the fields of neurodermatological and immune-inflammatory diseases. Their key products include AJ201, a novel drug for spinal and bulbar muscular atrophy, AJ302, a specific inhibitor for preventing chemotherapy-induced peripheral neuropathy, and AJ303, a compound aimed at treating idiopathic pulmonary fibrosis and other organ fibrosis diseases. The company aims to create first-in-class innovative drugs, including orphan drugs, to address significant medical needs. They are committed to advancing their research and development efforts to bring these therapies to market.Explore more
AnnJi Pharmaceutical Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AnnJi Pharmaceutical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on AnnJi Pharmaceutical recently announced quarterly report
Website visits: Recent activity has been detected on your website
AnnJi Pharmaceutical, which may be a good buyer, showed buying intent in Masked Content Topic
Check if AnnJi Pharmaceutical has recently received funding, and reach out quickly before it becomes old news!
Check out if AnnJi Pharmaceutical is spiking on competitors!
Click to see if AnnJi Pharmaceutical had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when AnnJi Pharmaceutical launches new products
Congratulate Masked Content for being promoted to Masked Content at AnnJi Pharmaceutical
Funding: Get notified immidiatlly once AnnJi Pharmaceutical has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
AnnJi Pharmaceutical is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
AnnJi Pharmaceutical is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about AnnJi Pharmaceutical.
AnnJi Pharmaceutical Tech Stack
A closer look at the technologies used by AnnJi Pharmaceutical
See more technologies
AnnJi Pharmaceutical News & Media
AnnJi Pharmaceutical Announced A Licensing Agreement With Avenue Therapeutics To Develop And Commercialize AJ201, A First-In-Class Clinical Asset For The Treatment Of Kennedy's Disease
TAIPEI, March 10, 2023 /PRNewswire/ -- AnnJi Pharmaceutical Co. (AnnJi) has entered into an exclusive license agreement with Avenue Therapeutics Inc. (Avenue, NASDAQ: ATXI) for the development and commercialization of AJ201 in the U.S., Canada, European Union, Great Britain, and Israel...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding AnnJi Pharmaceutical
Sign Up For FreeTo access detailed company insights
安基生技新藥股份有限公司 is a clinical-stage pharmaceutical company focused on the development of innovative small molecules (NCEs) targeting unmet medical needs in the fields of neurodermatological and immune-inflammatory diseases. Their key products include AJ201, a novel drug for spinal and bulbar muscular atrophy, AJ302, a specific inhibitor for preventing... Read More
